Koers Venus Medtech (Hangzhou) Inc.
Aandelen
2500
CNE100003PJ8
Medische apparatuur, benodigdheden & distributie
Vertraagde tijd
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
5,62 HKD | -0,71% | -.--% | -.--% |
Omzet 2023 | 491 mln. 67,99 mln. 532 mln. 63,1 mln. | Omzet 2024 * | 812 mln. 112 mln. 879 mln. 104 mln. | Marktkapitalisatie | 2,26 mld. 312 mln. 2,44 mld. 290 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2023 | -721 mln. -99,76 mln. -781 mln. -92,58 mln. | Nettowinst (verlies) 2024 * | -251 mln. -34,73 mln. -272 mln. -32,23 mln. | EV/omzet 2023 | 4,6 x |
Nettoliquiditeiten 2023 * | 410 mln. 56,67 mln. 443 mln. 52,59 mln. | Nettoschuld 2024 * | 125 mln. 17,31 mln. 135 mln. 16,07 mln. | EV/omzet 2024 * | 2,93 x |
K/w-verhouding 2023 |
-3,13
x | K/w-verhouding 2024 * |
-9,14
x | Werknemers | 1.006 |
Dividendrendement 2023 * |
-
| Dividendrendement 2024 * |
-
| Vrij verhandelbaar | 73,87% |
1 dag | -0,71% | ||
6 maanden | +15,40% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Hou-Sen Lim
CEO | Chief Executive Officer | 50 | 01-12-16 |
Fei Wang
DFI | Director of Finance/CFO | 47 | 04-01-23 |
Meirong Liu
BRD | Director/Board Member | 47 | 01-11-17 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Hou-Sen Lim
CEO | Chief Executive Officer | 50 | 01-12-16 |
Ting Yuk Wu
CHM | Chairman | 69 | 26-11-18 |
Wei Wang
BRD | Director/Board Member | 41 | 26-11-18 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.00% | 115 M€ | +5,14% | - | |
0.00% | 4 M€ | -4,41% | - | |
0.00% | 36 M€ | +4,92% | - |
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-.--% | 315 mln. | |
+19,51% | 136 mld. | |
-8,06% | 11,49 mld. | |
+14,97% | 10,12 mld. | |
+5,58% | 6,47 mld. | |
+10,83% | 3,51 mld. | |
+11,48% | 3,43 mld. | |
-11,54% | 2,08 mld. | |
-6,69% | 2 mld. | |
-27,32% | 1,68 mld. |